Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps

[1]  R. Birdwell,et al.  Patterns of Enhancement on Breast MR Images: Interpretation and Imaging Pitfalls , 2008 .

[2]  C. Gatsonis,et al.  MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. , 2007, The New England journal of medicine.

[3]  D. Vanel.  The American College of Radiology (ACR) Breast Imaging and Reporting Data System (BI-RADS): a step towards a universal radiological language? , 2007, European journal of radiology.

[4]  Francesco Sardanelli,et al.  Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection? , 2007, European Radiology.

[5]  E. Hauth,et al.  Evaluation of quantitative parametric analysis for characterization of breast lesions in contrast-enhanced MR mammography , 2006, European Radiology.

[6]  Jürgen Gieseke,et al.  Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience. , 2006, Radiology.

[7]  F. Schick,et al.  Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in Human Blood Plasma at 0.2, 1.5, and 3 Tesla , 2006, Investigative radiology.

[8]  J. Crowe,et al.  Increased ipsilateral whole breast vascularity as measured by contrast-enhanced magnetic resonance imaging in patients with breast cancer. , 2005, American journal of surgery.

[9]  C. Catalano,et al.  Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine. , 2005, Radiology.

[10]  Alessandro Carriero,et al.  Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. , 2005, Radiology.

[11]  Wei Huang,et al.  Detection of breast malignancy: diagnostic MR protocol for improved specificity. , 2004, Radiology.

[12]  Kazunori Taguchi,et al.  Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. , 2004, Journal of the American College of Surgeons.

[13]  A. Fausto,et al.  MR imaging of the breast: indications, established technique, and new directions , 2003, European Radiology.

[14]  J. Debatin,et al.  Using a 1 M Gd‐chelate (gadobutrol) for total‐body three‐dimensional MR angiography: Preliminary experience , 2003, Journal of magnetic resonance imaging : JMRI.

[15]  Elizabeth A Morris,et al.  MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. , 2003, AJR. American journal of roentgenology.

[16]  L. Bonomo,et al.  Maximum intensity projection analysis in magnetic resonance of the breast. , 2002, Journal of experimental & clinical cancer research : CR.

[17]  W. Heindel,et al.  Value of 1.0-M gadolinium chelates: review of preclinical and clinical data on gadobutrol , 2002, European Radiology.

[18]  W. Kaiser,et al.  Development, standardization, and testing of a lexicon for reporting contrast‐enhanced breast magnetic resonance imaging studies , 2001, Journal of magnetic resonance imaging : JMRI.

[19]  Bernd Hamm,et al.  Gadolinium-enhanced MR angiography of the breast: Is breast cancer associated with ipsilateral higher vascularity? , 2001, European Radiology.

[20]  N. Hylton.  Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging. , 2001, Magnetic resonance imaging clinics of North America.

[21]  E A Sickles,et al.  Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. , 2000, AJR. American journal of roentgenology.

[22]  P. Langenberg,et al.  Breast Imaging Reporting and Data System: inter- and intraobserver variability in feature analysis and final assessment. , 2000, AJR. American journal of roentgenology.

[23]  E Grabbe,et al.  Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. , 1999, Radiology.

[24]  G Brix,et al.  Pathophysiologic basis of contrast enhancement in breast tumors , 1999, Journal of magnetic resonance imaging : JMRI.

[25]  G. Glover,et al.  Breast disease: dynamic spiral MR imaging. , 1998, Radiology.

[26]  M D Schnall,et al.  Breast MR imaging: interpretation model. , 1997, Radiology.

[27]  P Aspelin,et al.  Sensitivity and Specificity of MR Mammography with Histopathological Correlation in 250 Breasts , 1996, Acta radiologica.

[28]  S. Edge,et al.  Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. , 1995, Radiology.

[29]  L J van Erning,et al.  MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. , 1994, Radiology.

[30]  M D Schnall,et al.  Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. , 1994, Radiology.

[31]  Sh. Heywang Kobrunner.  Contrast-enhanced magnetic resonance imaging of the breast , 1994 .

[32]  S E Harms,et al.  MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. , 1993, Radiology.

[33]  J. Douglas,et al.  Value of 1 , 1982 .